Grow Therapy Funding: $225M Raised, Series D (2026)
Grow Therapy is a Healthtech company based in New York. It has raised $225M in total funding. Latest round: Series D.
Grow Therapy funding overview
Grow Therapy is a Healthtech company based in New York. Grow Therapy has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in June 2026. The round record for Grow Therapy runs through 2026; nothing later has been disclosed. Investors on record include TCV, Growth Equity at Goldman Sachs Alternatives, BCI, Menlo Ventures, Sequoia, SignalFire and 1 others. 7 distinct backers are named across the disclosed rounds.
Grow Therapy at a glance
Total raised
$225M
Latest round
Series D
Latest round date
June 2026
Industry
Healthtech
Headquarters
New York
Notable investors
TCV, Growth Equity at Goldman Sachs Alternatives, BCI, Menlo Ventures, Sequoia, SignalFire, Transformation Capital
Frequently asked about Grow Therapy funding
How much has Grow Therapy raised?
Grow Therapy has raised $225M in total disclosed funding across the rounds on record.
Who has invested in Grow Therapy?
TCV, Growth Equity at Goldman Sachs Alternatives, BCI, Menlo Ventures, Sequoia, SignalFire are named among the investors backing Grow Therapy.
What was the latest Grow Therapy funding round?
The most recent disclosed round is a Series D, announced in June 2026.
Where is Grow Therapy based?
Grow Therapy is based in New York.
What sector does Grow Therapy operate in?
Grow Therapy is tracked under Healthtech from New York, with $225M in disclosed funding.
When did Grow Therapy last raise?
The last disclosed Grow Therapy round closed in June 2026 at Series D.
Every Grow Therapy figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in New York at a similar stage.
